Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Journal of Chemical Information and Modeling|March 28, 2006
Assessing the scaffold diversity of screening librariesMireille Krier, Guillaume Bret, Didier RognanJournal of Pharmaceutical Sciences|October 18, 2021
Atropisomerism - A Neglected Way to Escape Out of Solubility FlatlandsChristoph Saal, Axel Becker, Mireille Krier, et al.Journal of Computational Chemistry|September 15, 2010
Pharmacophore alignment search tool: Influence of canonical atom labeling on similarity searchingVolker Hähnke, Matthias Rupp, Mireille Krier, et al.Journal of Cheminformatics|February 4, 2019
Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial settingThierry Hanser, Fabian P Steinmetz, Jeffrey Plante, et al.Acta Crystallographica. Section E, Crystallographic Communications|July 20, 2022
Synthesis and crystal structure of rac-2-(1,3-dioxo-isoindolin-2-yl)ethyl 4-methyl-N-phenyl-N'-(tri-iso-propyl-sil-yl)benzene-sulfondiimidoate: the first member of a new substance classErik Friedrich, Timo Heinrich, Lara Rosenberger, et al.Chemmedchem|March 23, 2026
Strategic Key Performance Indicators for AI in Lead OptimizationTheodor Theis, Stefanie Flohr, Hayley Binch, et al.Bioorganic & Medicinal Chemistry Letters|March 23, 2011
Design and synthesis of isoquinolines and benzimidazoles as RAF kinase inhibitorsHans-Peter Buchstaller, Lars Burgdorf, Dirk Finsinger, et al.Bioorganic & Medicinal Chemistry Letters|August 27, 2013
Fragment-based discovery of focal adhesion kinase inhibitorsUlrich Grädler, Jörg Bomke, Djordje Musil, et al.Journal of Medicinal Chemistry|May 27, 2005
Design of small-sized libraries by combinatorial assembly of linkers and functional groups to a given scaffold: application to the structure-based optimization of a phosphodiesterase 4 inhibitorMireille Krier, João X de Araújo-Júnior, Martine Schmitt, et al.Journal of Medicinal Chemistry|January 9, 2013
Fragment-based discovery of new highly substituted 1H-pyrrolo[2,3-b]- and 3H-imidazolo[4,5-b]-pyridines as focal adhesion kinase inhibitorsTimo Heinrich, Jeyaprakashnarayanan Seenisamy, Lourdusamy Emmanuvel, et al.Pageof 2